Axi launches leveraged pre-IPO perpetuals linked to OpenAI and Anthropic, without share ownership

Online broker Axi says it has launched perpetual futures contracts linked to the anticipated private-market valuations of OpenAI and Anthropic, offering long and short exposure before conventional public share trading. Its 5 November company announcement, distributed on 6 November, describes around-the-clock dealing and leverage up to 25:1. The instruments are not company shares, cannot be exchanged for an ownership stake and do not make their buyers shareholders in either private business.[1]

That distinction is more significant than the branding. A trader acquiring a listed ordinary share has an identifiable security with a recognised ownership and settlement chain. A synthetic perpetual linked to a private company instead depends on the contract specification, pricing methodology and the entity that owes performance under the derivative. The announcement gives the broad concept but does not publish enough of the contract design for an independent calculation of fair value, basis or expected financing costs. Those documents would need separate examination before trading.[1]

Axi says the contracts trade 24 hours a day, seven days a week and support long and short positions. The maximum advertised leverage of 25:1 implies that a position’s notional value can be as much as twenty-five times the initial margin amount under the specified terms. On that simple ratio, a 4% adverse change in notional value would equal the original one-part-in-twenty-five margin before financing, fees, collateral changes or liquidation mechanics. This is an illustration of exposure, not a prediction that the instrument will move in line with any actual private share.[1]

Price discovery is the unresolved question. There is no public continuously traded underlying share on a conventional stock exchange for these names. A synthetic reference price may depend on broker models, third-party indications, derivatives liquidity or other market signals. In the material reviewed, Axi does not provide an independent public order book or an auditable methodology showing how its contracts map to private capital transactions. A reader should therefore distinguish the availability of a tradable price from proof of a reliable, independently observable private-company valuation.[1]

The company’s promotional release also includes assertions about the companies’ possible IPO plans, including a specific claimed filing by Anthropic. FXBrokers.ai has not treated that claim as independent confirmation of an IPO filing. The status of any actual securities registration, exchange admission and issuer announcement would require separate primary records. A brokerage marketing statement about a derivative must not be converted into a verified capital-market event at the referenced company.[1]

What to watch next

The product is promoted by AxiTrader LLC and the company says availability depends on jurisdiction. That makes the legal counterparty and local product restrictions critical. “Perpetual futures” is a commercial product description; the regulatory treatment and customer protection framework depend on the applicable entity and local law. Traders should establish funding rates, margin thresholds, forced-liquidation rules, contract denomination, valuation source and the consequences of an eventual IPO before assuming the synthetic price will converge to a public stock price.[1]

This launch illustrates the growing market for synthetic exposure to assets that private investors cannot ordinarily trade. Its significance is not that retail clients suddenly gain equity in major AI businesses, but that brokers are seeking to manufacture derivatives around demand for access. The next evidence that matters is the complete contract specification, independent price comparison and actual trading liquidity. Until those are disclosed, the verified headline is a new high-leverage derivative product with substantial underlying-value and counterparty uncertainty.[1]

Report an error or submit an update